Integrative analysis of GWAS and transcriptomics data reveal key genes for non-small lung cancer

被引:1
|
作者
Feng, Xiangxiong [1 ]
机构
[1] Univ Calif Davis, Shields Ave, Davis, CA 95616 USA
关键词
GWAS; Transcriptomics; Lung cancer; Machine learning; SUSCEPTIBILITY LOCI; RISK-FACTORS; ASSOCIATION; HETEROGENEITY; STATISTICS; SMOKING; DISEASE;
D O I
10.1007/s12032-023-02139-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is one of the world's most common and deadly cancers. The two main types of lung cancer are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). More than 85% of lung cancers are NSCLC. Genetic factors play a significant role in the risk of NSCLC. Growing studies focus on studying risk factors at the molecular level. The aim of the study is to build a pipeline to integrate Genome-wide association analysis (GWAS) and transcriptomics data with machine learning to effectively identify genetic risk factors of NSCLC. GWAS datasets and GWAS summary data were downloaded from GWAS catalog, which include lung carcinoma genetic variants among the European population. Then, with the GWAS summary, data functional analysis of significant SNPs was performed using a webserver called FUMAGWAS. The transcriptomics data of NSCLC and non-NSCLC people were used to build a machine learning model to identify the key genes that help predict the NSCLC. The top up-regulation and down-regulation genes were identified by the BART cancer webserver, and the mechanistic roles of the genes were validated by literature review. By performing integrative analysis of GWAS and transcriptomics analysis using machine learning, we identified multiple SNPs and genes that related to NSCLC. The computational pipeline may facilitate the biomarker discovery for NSCLC and other diseases.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Differential Gene Expression Analysis of Non-Small Cell Lung Cancer Samples to Classify Candidate Genes
    Hiremath, Neelambika B.
    Dayananda, Pruthviraja
    ENGINEERING TECHNOLOGY & APPLIED SCIENCE RESEARCH, 2023, 13 (02) : 10571 - 10577
  • [32] Semiparametric integrative interaction analysis for non-small-cell lung cancer
    Li Yang
    Wang Fan
    Li Rong
    Sun Yifan
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2020, 29 (10) : 2865 - 2880
  • [33] MUTATION ANALYSIS OF THE EGFR GENE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN XINJIANG
    Shi, Yi
    Pang, Xue-Lian
    Ma, Zhi-Ping
    Cui, Wen-Li
    Zhang, Wei
    Ma, Yu-Qing
    ACTA MEDICA MEDITERRANEA, 2021, 37 (06): : 3363 - 3368
  • [34] Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis
    Wang, Feng
    Liu, Yanhong
    Chen, Yan
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 84 : 1595 - 1600
  • [35] Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer
    Chavan, Pavan Ramrao
    Pandey, Ruchi
    Patil, Baswant Malesh
    Murti, Krishna
    Kumar, Nitesh
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998
  • [36] Bioinformatics analysis and validation of CSRNP1 as a key prognostic gene in non-small cell lung cancer
    Xu, Zhongneng
    Zhou, Hao
    Luo, Yonggang
    Li, Nunu
    Chen, Sheng
    HELIYON, 2024, 10 (07)
  • [37] Evaluation and Treatment of Patients with Non-Small Cell Lung Cancer
    Carr, Laurie L.
    Finigan, James H.
    Kern, Jeffrey A.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (06) : 1041 - +
  • [38] Small RNAs and non-small cell lung cancer
    Tong, Alex W.
    CURRENT MOLECULAR MEDICINE, 2006, 6 (03) : 339 - 349
  • [39] Computed tomography imaging of non-small cell lung cancer
    Chassagnon, G.
    Bennani, S.
    Revel, M. P.
    CANCER RADIOTHERAPIE, 2016, 20 (6-7): : 694 - 698
  • [40] Risk factor analysis of bone metastasis in patients with non-small cell lung cancer
    Li, Yang
    Xu, Chongqing
    Yu, Qiquan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (09): : 6696 - 6702